Clinical Oncology

Article	Citations
RCR Meetings	76
RCR Meetings	72
Radiotherapy Quality Assurance in the PORTEC-3 (TROG 08.04) Trial	44
Atomic Theory and Radioactivity	40
RCR Meetings	40
Instant Oncology: Lung ART	39
New Guidance From The Royal College of Radiologists on Incidental Irradiation of the Spleen: What Does it Say and Why Does it Matter?	38
Ayrshire Men Diagnosed with Locally Advanced Prostate Cancer between 2012 and 2013; How do they do?	37
Socioeconomic Deprivation Correlates With Incomplete Radiotherapy Treatment in Head and Neck Cancer	36
Reirradiation in Paediatric Tumours of the Central Nervous System: Outcome and Side Effects After Implementing National Guidelines	34
OSAIRIS: Lessons Learned From the Hospital-Based Implementation and Evaluation of an Open-Source Deep-Learning Model for Radiotherapy Image Segmentation	30
Real World Outcomes in Patients With Recurrent, Advanced, or Metastatic Endometrial Cancer Treated With Lenvatinib Plus Pembrolizumab	30
Instant Oncology: OPERA	28
OncoFlash: Research Updates in a Flash!	28
Switching to a Fixed-dose Combined Pertuzumab and Trastuzumab With Recombinant Human Hyaluronidase Subcutaneous Injection to Treat Human Epidermal Growth Factor Receptor 2-positive Breast Cancer in Re	27
Being a Good Educational Supervisor for Trainee Clinical Oncologists	26
COVID-19 Vaccine Prioritisation for Medical Students: The Forgotten Cohort?	25
In the Nexus of Transformation: Innovations, Challenges and the Future of Digital Oncology	25
Letter to the Editor Regarding the Article “PTV Margins in MR-guided and Beam-gated SBRT of Liver Metastases: GTV Dose Escalation Can Reduce the Required PTV”	25
Clinical Relevance of Immunohistochemical Subtypes in Early-Stage, Lymph Node-negative Breast Cancer. Results of a Large Cohort Study	24
Contemporary Long-term Survival Outcomes and Prognostic Factors in Adult grade 4 Astrocytoma: An Institutional Analysis	24
Impact of Delay in Healthcare Access on Anal Cancer Diagnosis	23
AI in healthcare: a rallying cry for critical clinical research and ethical thinking	22
RCR Meetings	21
OncoFlash – Research Updates in a Flash! (September Edition)	21

Stereotactic Ablative Radiotherapy for Oligometastatic Disease: A Tale of Emperor's New Clothes or New Standard of Care?	20
Imaging of Neck Nodes in Head and Neck Cancers – a Comprehensive Update	20
Failing to Close the Gap between Evidence and Clinical Practice in Radical Bladder Cancer Radiotherapy: A Critical Unmet Need	20
OncoFlash – Research Updates in a Flash! (April 2023)	20
RCR Meetings	20
Survival Outcomes for p16-positive Oropharyngeal Squamous Cell Carcinoma Based on Human Papillomavirus Status	20
Localised Synovial Sarcoma in Adolescents and Young Adults Versus Adults – Is There a Difference in Outcome?	19
RCR Meetings	19
Re: Growth and Nutritional Outcomes in Children Post-haematopoietic Stem Cell Transplant Without Exposure to Total Body Irradiation	18
Education to Improve Cancer Care for LGBTQ+ Patients in the UK	17
Deep Brain Stimulators and Radiation Therapy in Cancer Patients	17
Improving Concordance with Radiotherapy Protocols for Patients Undergoing Radical Radiotherapy for Prostate Cancer	17
RCR Meetings	17
Instant Oncology: RAPIDO	17
Hypofractionated Radiation Therapy in Keratinocyte Carcinoma	17
Impact of Adjuvant Treatment in pN3 Penile Cancer	16
Advancing Radiotherapy for Bladder Cancer: Randomised Phase II Trial of Adaptive Image-guided Standard or Dose-escalated Tumour Boost Radiotherapy (RAIDER)	16
Dosimetric and Clinical Predictors for Acute and Late Gastrointestinal Toxicity Following Chemoradiotherapy of Locally Advanced Anal Cancer	16
Immunotherapy and Systemic Therapy in Metastatic/Recurrent Endometrial and Cervical Cancers	15
Checklist for Improving Patient Communication on Bladder Preservation Options: The Patient Advocate Perspective	15
The Dawn of Another New Era	15
First-line Cemiplimab versus Standard Chemotherapy in Advanced Non-small Cell Lung Cancer Patients with at Least 50% Programmed Cell Death Receptor Ligand-1 Positivity: Analysis of Cost-effectiveness	15
Post-cricoid and Upper Oesophagus Cancers Treated with Organ Preservation Using Intensity-modulated Image-guided Radiotherapy: a Phase II Prospective Study of Outcomes, Toxicity and Quality of Life	15
Time to Rethink Commercialisation: Spin out or Lose out?	14
The Association Between Survival and Receipt of Post-mastectomy Radiotherapy According to Age at Diagnosis Among Women With Early Invasive Breast Cancer: A Population-Based Cohort Study	14
Analysis of the Safety and Pregnancy Outcomes of Fertility-sparing Surgery in Ovarian Malignant Sex Cord-stromal Tumours: A Multicentre Retrospective Study	14
In Response to: ‘Should We be Offering our Patients with Oligometastases Stereotactic Ablative Body Radiotherapy?’ by Ostler et al. and ‘Should We be Offering our Patients with Oligometastases Stereot	14
PulMiCC was Not ‘Unsuccessful’ and Stereotactic Ablative Body Radiotherapy is Not Like a Parachute: Comments on the Editorial by Ostler et al.	14
Impact of the COVID-19 Pandemic on Radiotherapy Interruptions and Patient Outcomes	14
Bladder Preservation With Radiotherapy: The Patient Perspective	14
Study Protocol of the Bladder Adjuvant RadioTherapy (BART) Trial: A Randomised Phase III Trial of Adjuvant Radiotherapy Following Cystectomy in Bladder Cancer	14
Role of Adjuvant Radiotherapy in Acinic Cell Carcinoma of the Salivary Glands: A Systematic Review	14
An Editorial Review of Prognostic Awareness and Considerations for the Clinical Setting	14
Is There Room for Liposomal Irinotecan in Biliary Tract Cancer? A Meta-analysis of Randomised Trials	13
Current Management Practices for Endometrial Cancer (EC) in the UK: A National Healthcare Professional Survey (KNOW-EC)	13
Cultivating Inclusivity and Bridging Gaps Through Reverse Mentoring: A Feasibility Study Within the Royal College of Radiologists	13
Cell-free DNA Testing in Lung Cancer Patients Improves National Health Service Real-world Result Turnaround Time and Treatment Initiation for Tumours with Targetable Alterations by 4 Weeks	13
Pharyngeal Constrictor Dose–Volume Histogram Metrics and Patient-Reported Dysphagia in Head and Neck Radiotherapy	13
RE: Pharyngeal Constrictor Muscle Sparing in Head and Neck Radiotherapy	13
The Use of Artificial Intelligence Technologies in Cancer Care	13
Variability in Kidney Cancer Treatment and Survival in England: Results of a National Cohort Study	12
Function Preservation in Head and Neck Cancers	12
Metabolic Profile of Cerebellum in Posterior Fossa Tumor Survivors: Correlation With Memory Impairment	12
Best-Practice Biomarker Testing of Oesophago-Gastric Cancer in the UK: Expert Consensus Recommendations Developed Using a Modified Delphi	12
Hypofractionated radiotherapy for pancreatic cancer	11
Audit of cabozantinib outcomes for metastatic renal cell carcinoma at Norfolk and Norwich University Hospital	11
Single institution outcomes of conventional (1.8–2 Gy/Fr) and hypofractionated (2.5–3 Gy/Fr) RT in OG/GOJ cancers during COVID-19	11
SARS-CoV-2 Infection and Antibody Seroprevalence among UK Healthcare Professionals Working with Cancer Patients during the First Wave of the COVID-19 Pandemic	11
Contact X-ray brachytherapy (CXB) for early rectal cancer: A review of outcomes from a single UK centre	11
An educational initiative to develop radiotherapy-specific teaching following the introduction of the oncology common stem year	11

A Single UK Centre's Real-world Experience with Cabazitaxel for Metastatic Castrate Resistant Prostate Cancer	11
The First Use of Stereotactic Ablative Body Radiotherapy (SABR) in Extra-cranial Non-lung Oligometastatic Disease: A Single Centre	10
‘No one Left Behind’: The Introduction of a Formal Malignancy of Unknown Origin (MUO) Pathway in a Large Regional Cancer Centre	10
3D conformal versus IMRT for early-stage squamous cell carcinoma of larynx	10
A Therapeutic Challenge: Chemo-refractory Non-metastatic Inflammatory Breast Cancers	10
Improving Waiting Times from Decision to Treat to Starting Treatment in Head and Neck Cancers: An Audit of the 17-day Pathway	10
A Sussex-wide Immunotherapy Toxicity Service to Optimise Patient Care and Redistribute Workload from Tumour-specific Oncologists	10
Treatment outcomes for stage I lung cancer in south-east Scotland	10
Dose to Organ at Risk and its Characteristic Variation with the Clinically Used Different Prescription Levels for Early-stage Left-sided Breast Cancer	10
Organ preservation in rectal cancer with short-course radiotherapy and a papillon boost: An international multicentre analysis	10
An Audit of Toxicity from Low-dose Rate (LDR) Prostate Brachytherapy – Assessment of a New Service	10
Improving Palliative Radiotherapy Training: A Multi-professional, Combined Clinical and Training Improvement Project	10
Evaluation of the impact of teaching on delineation variation during a virtual SABR contouring workshop	10
What is so Special About Digital Health in Cancer?	9
Instant Oncology: Impower133	9
Evaluating Delays in Commencing Adjuvant Treatment for Early Breast Cancer Following Oncotype Dx Testing	9
Current Practice of Apalutamide in Patients with Metastatic Hormone-sensitive Prostate Cancer	9
Assessing the Value of CT in the Staging and Management of High-risk Prostate Cancer Patients	9
A Dose of Reality: Embracing the Unseen to Improve Stereotactic Radiotherapy	9
Watch and Wait in Rectal Cancer After a Complete Response to Chemoradiotherapy – Is It Safe and Are We Doing Enough?	9
Breast Radiotherapy Consent Process in Kent Oncology Centre – a Patient’s Perspective	9
Dosimetry in the Prediction and Reduction of Acute Skin Toxicity from the Use of Brass Bolus in Postmastectomy Chest Wall Radiotherapy Treatment	9
Salvage Radiotherapy in Localised Prostate Cancer Patients over a 4-year Follow-up Period: Single Centre Analysis	9
In Response to the Correspondence to the Editor Regarding ʻExtra-mandibular Osteoradionecrosis After the Treatment of Head and Neck Cancer’	9
The Role of Contact X-Ray Brachytherapy in Early Rectal Cancer – Who, when and How?	9
OncoFlash – Research Updates in a Flash! (June 2022)	9
3D Conformal Radiotherapy versus Volumetric Modulated Arc Therapy in the Treatment of the Internal Mammary Chain and Supraclavicular Fossa in Adjuvant Breast Radiotherapy	9
Looking Forward	9
Chemoradiotherapy for Muscle-invasive Bladder Cancer; 5-year Survival Outcomes, the Edinburgh Cancer Centre Experience	9
A Retrospective Evaluation of Clinical Outcomes of Patients Undergoing Cystectomy for Bladder Cancer at a Specialist Centre; Real-world Data from University College London Hospital	9
Perspectives of Healthcare Professionals on the Management and Treatment of Advanced Ovarian Cancer in the UK: Results From the KNOW-OC Survey	9
The Clinical Features and Outcomes of Pseudocirrhosis in Breast Cancer: The Royal Marsden Hospital Experience	8
Audit to Evaluate Recurrence Rates in Patients with DCIS Treated with Adjuvant Radiotherapy and the Role of Endocrine Treatment	8
Decision Regret among Patients with Early-stage Lung Cancer Undergoing Radiation Therapy or Surgical Resection	8
A Potential Blind Spot in Breast Radiotherapy: The Importance of Volume in Breast Boosts	8
Relapse Rate in Patients Avoiding Adjuvant Chemotherapy Based on Oncotype DX Score – Real-world Data from the Kent Oncology Centre	8
Single-centre Experience Comparing PBI to WBRT and the Effects on Volume of Breast Tissue Treated, Heart and Lung Dosimetry	8
Dose-dense Paclitaxel and Carboplatin as Neoadjuvant Chemotherapy for Stage IIB/IIIA Non-small Cell Lung Cancer – A Phase II trial	8
Using Proteome Microarray and Gene Expression Omnibus Database to Screen Tumour-Associated Antigens to Construct the Optimal Diagnostic Model of Oesophageal Squamous Cell Carcinoma	8
Health Inequality in Breast Cancer Patients: a Single Institution Review	8
Assessing the Tolerability of Adjuvant and Neoadjuvant Chemotherapy in the Treatment of Early and Locally Advanced Breast Cancer in the Elderly Population at a UK Tertiary Cancer Centre	8
Systematic Review of Hypofractionated Radiation Therapy for the Treatment of Oesophageal Squamous Cell Carcinoma and Oesophageal Adenocarcinoma	8
What can the Interventional Endoscopist Offer in the Management of Upper Gastrointestinal Malignancies?	7
Assessing Symmetry and Accuracy of SpaceOAR Insertion Prior to Radical Radiotherapy to the Prostate: a Single UK Centre Experience	7
Comparison of VMAT Plans between Clinac iX and Halcyon for Nasopharyngeal carcinoma patients	7
Simultaneous Modulated Accelerated Radiotherapy (SMART) in Intermediate and High Risk Oropharyngeal Squamous Cell Carcinoma	7
Interventions for Managing Late Gastrointestinal Symptoms Following Pelvic Radiotherapy: a Systematic Review and Meta-analysis	7
Response to Mistry: Radiosensitivity index is not fit to be used for dose adjustments: A pan-cancer analysis	7
Rationale and Design of a Phase II Trial of Combined Serplulimab and Chemotherapy in Patients with Histologically Transformed Small Cell Lung Cancer: a Prospective, Single-arm and Multicentre Study	7
The “real” outcome of esophageal cancer in elderly.	7
Dose-Painting Proton Radiotherapy Guided by Functional MRI in Non-enhancing High-Grade Gliomas	7
Authors' Response to Correspondence Re Ethnic Differences in Radiotherapy Outcomes in a Majority South Asian Leicester Community	7
Regarding ‘Assessment of Upfront Selection Criteria to Prioritise Patients for Breath-Hold Left-Sided Breast Radiotherapy’ by Tanna et al	7
The Beatson Experience of Hydrogel Vue Rectal Spacers in Patients at High Risk of Rectal Toxicity from Prostate Radiotherapy	7
Another Brick in the Wall … no More! Breaking the Sex Bias	7
OncoFlash–Research Updates in a Flash! (December 2022)	7
Study evaluating clinical and histopathological response of neoadjuvant chemotherapy in patients of locally advanced breast cancer - A Prospective Study	7
Provision of Palliative Combined Pembrolizumab–Chemotherapy in Head and Neck Cancer in England: Time for a Review of the Evidence	7
Real-world Outcomes of Bladder Carbogen and Nicotinamide (BCON) in Muscle-invasive Bladder Cancer (MIBC)	7
The Increasing Role of Genomics Testing in Thyroid Cancers	7
The Time has Come to Say Goodbye	7
How Low Can You Go? The Radiobiology of Hypofractionation	6
Curative-Intent Radiotherapy for Squamous Cell Carcinoma of the Head and Neck in Sri Lanka: The Impact of Radiotherapy Technique on Survival	6
Real-World Efficacy of Nintedanib Plus Docetaxel After Progression on Immune Checkpoint Inhibitors: Results From the Ongoing, Non-interventional VARGADO Study	6
Intensified Total Neoadjuvant Therapy in Patients With Locally Advanced Rectal Cancer: A Phase II Trial	6
Exploiting Deep Learning to Enhance Tumour-conformed Delineation and Reduced Isotropic Margin in Radiotherapy: Updated ESTRO-EANO Guidelines	6
Concurrent Chemoradiotherapy versus Radiotherapy Alone in the Treatment of Stage II and T3N0M0 Nasopharyngeal Carcinoma: A Systematic Review and Meta-Analysis	6
When Less is More: The Rising Tide of Hypofractionation	6
Hidden Neoplasm Detection in Patients With Venous Thromboembolism: An Unresolved Dilemma	6
Comparative Analysis of Stereotactic Radiation Therapy and Conventional Radiation Therapy in Cancer Pain Control: A Systematic Review and Meta-Analysis	6
Clinical Outcomes of Hypo-fractionated Radiotherapy and Intercalated Brachytherapy in Cervical Carcinoma: A Prospective Clinical Study	6
Defining the Optimal Treatment Strategy in Patients With Uterine Serous Carcinoma	6
A retrospective audit of radical bladder radiotherapy for muscle invasive bladder cancer (MIBC) outcomes at the Dorset Cancer Centre	6
Breast cancer MDT streamlining: Current oncology UK practice	6
Radiomics in Oncology and Radiology: Statistical Significance Versus Clinical Significance	6
Relationship of Urethral Dose and Genitourinary Toxicity Among Patients Receiving Vaginal High Dose Rate Interstitial Brachytherapy	6
RCR Meetings	6
RCR Meetings	6
Quality of Radiotherapy Workforce Training within the USA	6
Is exercise an important consideration in metastatic breast cancer?	6

Adaptive Radiotherapy in the Management of Cervical Cancer: Review of Strategies and Clinical Implementation	5
Clinical Impact of Constitutional Genomic Testing on Current Breast Cancer Care	5
The UK National Oesophagogastric Multidisciplinary Team Meeting: An Initiative From the UK & Ireland Oesophagogastric Group	5
A retrospective audit of adherence to the IMPORT-HIGH recommendations on clip placement to facilitate breast boost radiotherapy	5
Impact of [18F]PSMA-1007 PET/CT on management of biochemical recurrence and high-risk staging of prostate cancer patients: A UK single centre experience	5
Can Testosterone Therapy Be a Viable Option for Men Suffering With the Effects From Hypogonadism due to Prostate Cancer Treatment?	5
Modern Tools for Modern Brachytherapy	5
Radiation Therapy in Non-Melanoma Skin Cancers: An Italian Survey on Behalf of the Italian Association of Radiotherapy and Clinical Oncology	5
OncoFlash May 2023 Edition	5
Implementation of Oncotype Dx to Guide Chemotherapy Sparing for Women with Postmenopausal N1-3, ER-positive, HER-2-negative Breast Cancer	5
Digital Medicine in Men with Advanced Prostate Cancer – A Feasibility Study of Electronic Patient-reported Outcomes in Patients on Systemic Treatment	5
Safeguarding Clinical Research in the National Health Service	5
A Single-Institution Review of the Use of Radiation in the Adjuvant and Definitive Management of Keloids	5
Radiologists in Head and Neck Cancers Radiotherapy Peer Review	5
Safe and Ethical Artificial Intelligence in Radiotherapy – Lessons Learned From the Aviation Industry	5
Real-world data (RWD) from patients with triple-negative breast cancer (TNBC) receiving pembrolizumab with neoadjuvant chemotherapy (NACT+P) versus NACT alone	5
Is Substantial Lymphovascular Space Invasion Prognostic for Clinical Outcomes in Type II Endometrial Cancer?	5
Sequencing Targeted Therapy in Era of Precision Medicine for Thyroid Cancers	5
Risk-group Classification by Recursive Partitioning Analysis of Patients Affected by Oligometastatic Renal Cancer Treated with Stereotactic Radiotherapy	5
Clinical Feasibility of Using Single-isocentre Non-coplanar Volumetric Modulated Arc Therapy Combined with Non-coplanar Cone Beam Computed Tomography in Hypofractionated Stereotactic Radiotherapy for	5
Vascular Interventions in Oncology	5
Response Letter to Laurelli et al. Letter to the Editor Regarding Enhancing Telemedicine to Improve Global Radiotherapy Access	5
NICE Technology Appraisals in Breast Oncology and the Impact on Cancer Treatment Unit Activity at the Sussex Cancer Network – 10-year Update	5
Metronomic Temozolomide in Heavily Pretreated Patients With Recurrent Isocitrate Dehydrogenase Wild-type Glioblastoma: A Large Real-Life Mono-Institutional Study	5
South West Regional Experience of Alpelisib and Fulvestrant in Patients with a PIK3CA Mutation	5
RCR Meetings	5
Creating a Sustainable Future of Radiotherapy Following COP26: A Case for Lung Stereotactic Ablative Radiotherapy Over Surgery?	5
Global Longitudinal Strain for the Early Detection of Chemotherapy-Induced Cardiotoxicity: A Systematic Review and Meta-analysis	5
The Management of Oligometastases in Non-small Cell Lung Cancer – is Stereotactic Ablative Radiotherapy now Standard of Care?	5
OncoFlash—Research Updates in a Flash!	5
Endometrial Cancer: Analysing Patterns of Recurrence and Real-Life Outcome Data Using the 2020 ESGO-ESTRO-ESP Risk Stratification System	5
Novel Therapies in Triple-negative Breast Cancer: Can less be More?	5
Real-world outcome data from patients with non-metastatic prostate cancer treated with primary androgen deprivation therapy	5
The Evidence for Low-level Laser Therapy for Oral Mucositis in Head and Neck Cancer Radiotherapy	5
Can Real-world Data and Rapid Learning Drive Improvements in Lung Cancer Survival? The RAPID-RT Study	5
Geographical Variation in Underlying Social Deprivation, Cardiovascular and Other Comorbidities in Patients with Potentially Curable Cancers in England: Results from a National Registry Dataset Analys	5
Audit of Hypersensitivity Reactions (HSRs) of Patients with Breast Cancer being Treated with Nab-paclitaxel after Severe HSR to Prior Taxane Chemotherapy; is it Safe?	5
Significance of Complete Metabolic Response to First-line Taxane/Trastuzumab and Pertuzumab for Advanced HER2+ Breast Cancer: a Single Centre Experience	5
Combining the Best of Both Worlds: The Role of Sequential Stereotactic Radiotherapy Boost for Spinal Metastases	5
Patient-reported Quality of Life following Stereotactic Body Radiation Therapy for Primary Kidney Cancer – Results from a Prospective Cohort Study	5
Computed Tomography and 18F-Fluorodeoxyglucose-Positron Emission Tomography/Computed Tomography Imaging Biomarkers of Lung Invasive Non-mucinous Adenocarcinoma: Prediction of Grade 3 Tumour Based on W	5
Surgical Treatments of Benign Prostatic Hyperplasia and Prostate Cancer Stereotactic Radiotherapy: Impact on Long-Term Genitourinary Toxicity	4
Overall Survival Prognostic Modelling of Non-small Cell Lung Cancer Patients Using Positron Emission Tomography/Computed Tomography Harmonised Radiomics Features: The Quest for the Optimal Machine Lea	4
Age-specific socioeconomic inequalities in treatment in patients with stage III colon cancer in England 2012 – 2016: a population-based study with mediation analysis	4
Adopting Machine Learning Auto-Segmentation Into Radiotherapy Workflow	4
Deintensification of Radiotherapy Use in Treatment of Ductal Carcinoma In Situ in the Netherlands–A Nationwide Overview From 2008 Until 2022	4
RCR Meetings	4
OncoFlash – Research Updates in a Flash! (July 2023)	4
Instant Oncology: FLAME	4
HDR Prostate Brachytherapy Boost for T3b Cancer: The Stokes Centre for Urology Experience	4
In Reply to Onal et al	4
Dual-Centre Harmonised Multimodal Positron Emission Tomography/Computed Tomography Image Radiomic Features and Machine Learning Algorithms for Non-small Cell Lung Cancer Histopathological Subtype Phen	4
Patient-Reported Outcomes and Health-Related Quality of Life Following Radiotherapy for Bladder Cancer	4
A Short Report Examining the Introduction of Routine Use of Patient-Reported Outcome Measures in a Mixed Oncology Population	4
OncoFlash – Research Updates in a Flash!	4
Advanced Cancer Patients' Prognostic Awareness and Its Association With Anxiety, Depression and Spiritual Well-Being: A Multi-Country Study in Asia	4
Patient-reported Late Effects of Single Fraction Total Body Irradiation for Non-malignant Haematological Disease Transplant Conditioning	4
OncoFlash – Research Updates in a Flash! (December 2023 edition)	4
RCR Meetings	4
Body Composition and Dose-limiting Toxicity in Colorectal Cancer Chemotherapy Treatment; a Systematic Review of the Literature. Could Muscle Mass be the New Body Surface Area in Chemotherapy Dosing?	4
Early Diagnosis and Lung Cancer Screening	4
Launch of the National Rectal Cancer Intensity-Modulated Radiotherapy Guidance	4
Management of Leptomeningeal Carcinomatosis with Intrathecal Chemotherapy (IT) in Breast Cancer Patients: Single Centre Experience from Guy’s Cancer	4
Developing UK Guidance on How Long Men Should Abstain from Receiving Anal Sex before, During and after Interventions for Prostate Cancer	4
Model-Based Selection for Proton Therapy in Breast Cancer: Development of the National Indication Protocol for Proton Therapy and First Clinical Experiences	4
The Rise of Supportive Oncology: A Revolution in Cancer Care	4
Global Research on the Treatment of Cancer Patients During the COVID-19 Pandemic: Visualisation and Bibliometric Analysis	4
Response to Mistry: Radiosensitivity Index is Not Fit to be Used for Dose Adjustments: A Pan-Cancer Analysis	4
A Systematic Review of Deep Inspiration Breath Hold and Free Breathing in Proton Beam Therapy Plans for Breast Cancer Radiotherapy	4
COVID-19 Vaccination in Oncology Patients Receiving Chemotherapy	4
Multi-Institutional Clinical Outcomes of Biopsy Gleason Grade Group 5 Prostate Cancers Treated With Contemporary High-Dose Radiation and Long-Term Androgen Deprivation Therapy	4
National Institute for Health and Care Excellence and Royal College of Radiologists' Fractionation Guideline for Metastatic Spinal Cord Compression	4
Machine Learning for Auto-Segmentation in Radiotherapy Planning	4
Re: Metastasis-directed Therapy in Prostate Cancer: Prognostic Significance of the ESTRO/EORTC Classification in Oligometastatic Bone Disease	4
OncoFlash – Research Updates in a Flash! (October edition)	4
Artificial Intelligence for Radiation Treatment Planning: Bridging Gaps From Retrospective Promise to Clinical Reality	4
Publisher’s Note	3
A Randomised Clinical Feasibility Trial of a Breast Immobilisation Device: The SuPPORT 4 All Bra	3
Clinicopathological Profile and Survival Outcomes in Patients with Localised Extremity Synovial Sarcomas	3
Growing Evidence for a Need for a Greater Emphasis on Oncology Teaching in Medical School Curricula	3
Does Mastectomy Reduce Overall Survival in Early Stage Breast Cancer?	3
Brachytherapy for Organ and Function Preservation in Soft-Tissue Sarcomas in Adult and Paediatric Patients	3
The Practice of Paediatric Radiation Oncology in Low- and Middle-income Countries: Outcomes of an International Atomic Energy Agency Study	3
A five-year review of chemoradiotherapy in anal cancer: Audit results from a cancer centre in Wales, UK	3
Use of Radiomics Models in Preoperative Grading of Cerebral Gliomas and Comparison with Three-dimensional Arterial Spin Labelling	3
Characteristics of Patients Treated for Breast Cancer Associated Breast Oedema at a UK Tertiary Hospital	3
Gut Microbiota Predict Efficacy of Neoadjuvant Systemic Therapy in Patients with Early Breast Cancer	3
Intensity-modulated Radiotherapy for Rectal Cancer in the UK in 2020	3
OncoFlash – Research Updates in a Flash! (October 2022)	3
Blood transfusions in oncology patients: The NNUH experience	3
The National Cancer Research Institute Clinical and Translational Radiotherapy Research Working Group Workshop: Translating Novel Discoveries to and from the Clinic	3
Early Mortality After Curative-intent Radiotherapy in Patients With Locally Advanced Non-small Cell Lung Cancer—A Population-based Cohort Study	3
Bladder Cancer: New Insights Into Dose, Volume and Prognostic Biomarkers	3
Baseline MD Anderson Symptom Inventory Score is Strongly Associated With Patient-reported Acute and Late Toxicity Following (Chemo) Radiotherapy for Head and Neck Cancers	3
Is it time to move from the Unidimensional RECIST 1.1 Response Assessment Criteria to a Volumetric Evaluation in the Present Era of Image-based Oncology? An Evaluation in Locally Advanced Head Neck Ca	3